Clinical Trial Update: Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r) [NA]

View source ↗

Summary

This clinical trial update reports on the preservation and expansion of T-cell subsets after de-intensifying HAART to atazanavir/ritonavir (ATV/r) in HIV infect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ATAZANAVIR (atazanavir)
• Atazanavir/ritonavir (atazanavir/ritonavir)
• Ritonavir (Ritonavir)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV Infections | NA | Status: COMPLETED | Results posted: 2016-06-24